The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients

BACKGROUND: Cytomegalovirus (CMV) infections in hematopoietic cell transplant (HCT) recipients cause substantial morbidity and mortality. CMV cell-mediated immunity (CMV-CMI) can be determined by levels of interferon gamma (IFN-γ) production using an enzyme-linked immunospot (ELISPOT) CMV assay (T-S...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Infect Dis
Glavni autori: El Haddad, Lynn, Ariza-Heredia, Ella, Shah, Dimpy P, Jiang, Ying, Blanchard, Ted, Ghantoji, Shashank S, El Chaer, Firas, El-Haddad, Danielle, Prayag, Amrita, Nesher, Lior, Rezvani, Katy, Shpall, Elizabeth, Chemaly, Roy F
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Major Articles and Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386808/
https://ncbi.nlm.nih.gov/pubmed/30295846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy592
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items